1. Wada Y, Maekawa M* (corresponding author), Ohnishi T, Balan S, Matsuoka S, Iwamoto K, Iwayama Y, Ohba H, Watanabe A, Hisano Y, Nozaki Y, Toyota T, Shimogori T, Itokawa M, Kobayashi T, Yoshikawa T*: Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia. EBioMedicine. DOI: 10.1016/j.ebiom.2020.103130.
2. Maekawa M* (corresponding author), Ohnishi T, Toyoshima M, Hamazaki K, Takagai S, Tsuchiya KJ, Nakamura K, Iwata Y, Nara T, Iwayama Y, Toyota T, Shimamoto-Mitsuyama C, Nozaki Y, Ohba H, Watanabe A, Hisano Y, Esaki K, Balan S, Wada Y, Tsujii M, Mori N, Matsuzaki H, Yoshikawa T*: A potential role of fatty acid binding protein 4 in the pathophysiology of autism spectrum disorder. Brain Commun. 2(2): fcaa145, 2020
3. Ohnishi T, Kiyama Y, Arima-Yoshida F, Kadota M, Ichikawa T, Yamada K, Watanabe A, Ohba H, Tanaka K, Nakaya A, Horiuchi Y, Iwayama Y, Toyoshima M, Ogawa I, Shimamoto-Mitsuyama C, Maekawa M, Balan S, Arai M, Miyashita M, Toriumi K, Nozaki Y, Kurokawa R, Suzuki K, Yoshikawa A, Toyota T, Hosoya T, Okuno H, Bito H, Itokawa M, Kuraku S, Manabe T, ※Yoshikawa T. Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia. EMBO Mol Med. e12574. 2021. doi: 10.15252/emmm.202012574. <謝辞の記載を失念したため>
4. Balan S, Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Toyoshima M, Hara T, Hisano Y, Miyasaka Y, Toyota T, Shimamoto-Mitsuyama C, Maekawa M, Numata S, Ohmori T, Shimogori T, Kikkawa Y, Hayashi T, ※Yoshikawa T. Role of an atypical cadherin gene, Cdh23 in prepulse inhibition and implication of CDH23 in schizophrenia. Schizophr Bull. sbab007. 2021. doi: 10.1093/schbul/sbab007. <謝辞の記載を失念したため>
5. Usui N, Iwata K, Miyachi T, Takagai S, Wakusawa K, Nara T, Tsuchiya KJ, Matsumoto K, Kurita D, Kameno Y, Wakuda T, Takebayashi K, Iwata Y, Fujioka T, Hirai T, Toyoshima M, Ohnishi T, Toyota T, Maekawa M, Yoshikawa T, Maekawa M, Nakamura K, Tsujii M, Sugiyama T, Mori N, ※Matsuzaki H. VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction. EBioMedicine. 58, 102917. 2020. doi: 10.1016/j.ebiom.2020.102917. <謝辞の記載を失念したため>
6. Shimamoto-Mitsuyama C, Nakaya A, Esaki K, Balan S, Iwayama Y, Ohnishi T, Maekawa M, Toyota T, Dean B, ※Yoshikawa T. Lipid pathology of the corpus callosum in schizophrenia and the potential role of abnormal gene regulatory networks with reduced microglial marker expression. Cerebral CORTEX. 31(1): 448-462. 2021. doi: 10.1093/cercor/bhaa236. <謝辞の記載を失念したため>